Dr Reddy's Laboratories (DRREDDY) News Today Add Share Share Headlines Stock AnalysisBuy This Stock DRREDDY Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Dr Reddy's Lab receives EIR from USFDA for Telangana API facilityAugust 11 at 12:26 PM | msn.comDr Reddys Laboratories Ltd soars 1.07%August 11 at 7:25 AM | msn.comDr. Reddy's Laboratories Price Target Cut By Citi Over Intensifying Generic Competition — Full DetailsAugust 4, 2025 | msn.comFive Stocks To Buy: Jio Financial Services, Tata Chemicals, Dr. Reddy's LaboratoriesJuly 30, 2025 | msn.comNomura Sticks to Its Buy Rating for Dr. Reddy’s Laboratories Ltd. (DRREDDY)July 29, 2025 | theglobeandmail.comDr Reddys Laboratories Ltd soars 0.02%, rises for fifth straight sessionJuly 29, 2025 | msn.comSun Pharma, Lupin, Dr Reddy's recall products in US market due to manufacturing issuesJuly 27, 2025 | msn.comDr. Reddy’s Laboratories Ltd. (DRREDDY) Receives a Hold from Goldman SachsJuly 25, 2025 | theglobeandmail.comDr. Reddy’s Laboratories Ltd. (DRREDDY) Gets a Sell from JefferiesJuly 25, 2025 | theglobeandmail.comDr Reddy's Laboratories Q1 Results: Profit Up 1.8%, Misses EstimatesJuly 24, 2025 | msn.comDr Reddy's Q1 FY26 results: PAT up 2% at Rs 1,418 crore, revenue climbs 11%July 24, 2025 | msn.comGoldman Sachs Remains a Hold on Dr. Reddy’s Laboratories Ltd. (DRREDDY)July 18, 2025 | theglobeandmail.comDr. Reddy’s Laboratories Ltd. (DRREDDY) was downgraded to a Hold Rating at MacquarieJuly 12, 2025 | theglobeandmail.comDr. Reddy's Laboratories slides Thursday, underperforms marketJuly 10, 2025 | marketwatch.comDr. Reddy's Laboratories climbs Monday, outperforms competitorsJuly 7, 2025 | marketwatch.comDr. Reddy's Laboratories slides Wednesday, underperforms marketJuly 2, 2025 | marketwatch.comDr. Reddy's Laboratories rises Tuesday, outperforms competitorsJune 25, 2025 | marketwatch.comDr. Reddy's Laboratories slips Friday, underperforms competitorsJune 20, 2025 | marketwatch.comDr. Reddy's Laboratories shares rise 4%: Two factors fueling the rally todayJune 5, 2025 | msn.comDr Reddys Lab gains on global biosimilar deal with AlvotechJune 5, 2025 | msn.comOzempic-Like Drug Not To Be Sold In India, Says Dr Reddy To Delhi High CourtJune 1, 2025 | msn.comDr. Reddy's Laboratories advances Thursday, underperforms marketMay 29, 2025 | marketwatch.comDr Reddys Labs' manufacturing facility gets two form 483 observations from US FDAMay 26, 2025 | msn.comDr. Reddy's Laboratories advances Friday, outperforms competitorsMay 23, 2025 | marketwatch.comDr. Reddy's Laboratories slides Thursday, still outperforms marketMay 22, 2025 | marketwatch.comDr. Reddy's Laboratories slides Monday, underperforms marketMay 19, 2025 | marketwatch.comStock to watch: Dr. Reddy's gets two observations from USFDAMay 19, 2025 | msn.comDr. Reddy’s Labs stock in focus amid FDA inspection report, Q4 resultsMay 19, 2025 | msn.comDr Reddy's receives two USFDA observations for New York API facilityMay 18, 2025 | msn.comDr Reddy's Gets Two Observations From US FDA For New York API PlantMay 17, 2025 | msn.comDr Reddy's NY API plant gets USFDA Form 483 with 2 observationsMay 17, 2025 | msn.comDr. Reddy's Laboratories slides Friday, underperforms competitorsMay 16, 2025 | marketwatch.comDr. Reddy's Laboratories advances Thursday, outperforms competitorsMay 15, 2025 | marketwatch.comDr. Reddy's Laboratories climbs Wednesday, outperforms competitorsMay 14, 2025 | marketwatch.comDr. Reddy’s Shares Eye Breakout As Q4 Beat Lifts Stock Toward ₹1,220 Resistance: SEBI RA Prameela BalakkalaMay 12, 2025 | msn.comDr. Reddy's Laboratories Q4 Results: Profit Rises 22%, Beats EstimatesMay 10, 2025 | msn.comGroup joins Sen. Cassidy to tour Dr. Reddy’s former lab for future economic developmentMay 9, 2025 | msn.comDr. Reddy's Laboratories Q4 Results: Profit Rises 22%, Beats EstimateMay 9, 2025 | msn.comDr. Reddy's Laboratories advances Friday, outperforms marketMay 9, 2025 | marketwatch.comLouisiana Sen. Cassidy tours Dr. Reddy’s former lab for future economic developmentMay 9, 2025 | yahoo.comDr. Reddy's Q4 Results Preview: Biosimilars To Drive Revenue GrowthMay 8, 2025 | msn.comDr. Reddy's Laboratories falls Thursday, outperforms competitorsMay 8, 2025 | marketwatch.comDr Reddy's Q4 Results: Date, Dividend News, Earnings Call Schedule And Other Key DetailsMay 8, 2025 | msn.comIndian Pharma Stocks On The Edge: SEBI RA Vikash Bagaria Warns Of Breakdown In Dr Reddy’s Shares Amid US Policy JittersMay 6, 2025 | msn.comDr. Reddy's Laboratories slides Tuesday, outperforms competitorsMay 6, 2025 | marketwatch.comDr. Reddy's Laboratories falls Monday, underperforms competitorsMay 5, 2025 | marketwatch.comDr Reddy's to bring Sanofi's novel RSV drug to Indian marketApril 29, 2025 | msn.comDr Reddy's to introduce Sanofi's novel drug in IndiaApril 28, 2025 | msn.comDr. Reddy's Laboratories advances Thursday, outperforms marketApril 24, 2025 | marketwatch.comDr. Reddy's Laboratories rallies Wednesday, underperforms competitorsApril 23, 2025 | marketwatch.com Get Dr Reddy's Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for DRREDDY and its competitors with MarketBeat's FREE daily newsletter. Email Address DRREDDY Media Mentions By Week DRREDDY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DRREDDY News Sentiment▼-0.181.28▲Average News Sentiment DRREDDY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DRREDDY Articles This Week▼22▲DRREDDY Articles Average Week Get Dr Reddy's Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for DRREDDY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:DRREDDY) was last updated on 8/12/2025 by MarketBeat.com Staff From Our Partners#1 Pre-IPO Opportunity For 2025 [Take Action Now!]James Altucher has scored 37X and even 60X returns on past pre-IPO deals. But now he says a much bigger opport...Paradigm Press | SponsoredThe stealth altcoin the financial world is underestimatingThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn your "dead money" into $306+ monthly (starting this month)Turn your "dead money" into $306+ monthly (starting this month) I've been tracking a financial revolution t...Investors Alley | SponsoredMy shocking meeting in Washington, D.C.After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look...Brownstone Research | SponsoredBig Changes Coming in August — Is Your IRA Ready?Banks aren’t waiting for the headlines to catch up. They’ve already started moving their wealth out of pape...Reagan Gold Group | SponsoredSilver Demand Is Exploding—and Supply Can’t Keep UpElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr Reddy's Laboratories Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dr Reddy's Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access